192
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Formulation and in vitro and in vivo evaluation of surfactant-stabilized mucoadhesive nanogels for vaginal delivery of fluconazole

, , , , , , , , ORCID Icon, , & show all
Pages 1935-1942 | Received 16 Jun 2021, Accepted 22 Apr 2022, Published online: 10 May 2022

References

  • Nagarkar R, Patel M, Babar A. Novel emulsion base for vaginal yeast infection with half drug concentration. Indian J Pharm Biol Res. 2020;8:1–11.
  • Joshi V, Yashaswini G, Acharya A, et al. Formulation and evaluation of semisolid dosage forms of an anti-inflammatory drug. 3 Biotech. 2019;9:E248.
  • Hussain A, Ahsan F. The vagina as a route for systemic drug delivery. J Control Release. 2005;103(2):301–313.
  • Garg S, Tambwekar KR, Vermani K, et al. Development pharmaceutics of microbicide formulations. Part II: formulation, evaluation, and challenges. AIDS Patient Care STDS. 2003;17(8):377–399.
  • Lalan MS, Patel VN, Misra A. Polymers in vaginal drug delivery: recent advancements. In Applications of polymers in drug delivery. New York (NY): Elsevier; 2012. p. 281–303.
  • Patil MV, Jadhav RL, Shaikh SN, et al. Formulation and evaluation thermoreversible gel of antifungal agent for treatment of vaginal infection. JPRI. 2020;32:58–66.
  • Justin-Temu M, Damian F, Kinget R, et al. Intravaginal gels as drug delivery systems. J Womens Health. 2004;13(7):834–844.
  • Cunningham FE, Kraus DM, Brubaker L, et al. Pharmacokinetics of intravaginal metronidazole gel. J Clin Pharmacol. 1994;34(11):1060–1065.
  • Edsman K, Carlfors J, Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci. 1998;6(2):105–112.
  • Sandri G, Rossi S, Ferrari F, et al. Assessment of chitosan derivatives as buccal and vaginal penetration enhancers. Eur J Pharm Sci. 2004;21(2–3):351–359.
  • Barry B, Meyer M. The rheological properties of carbopol gels I. Continuous shear and creep properties of carbopol gels. Int J Pharm. 1998;2:105–112.
  • Saito S, Taniguchi T. Precipitation of nonionic surfactants by polymeric acid. J Am Oil Chem Soc. 1973;50(8):276–277.
  • DiBiase M, Rhodes C. Investigations of epidermal growth factor in semisolid formulations. Pharm Acta Helv. 1991;66(5–6):165–169.
  • Unlü N, Ludwig A, Van MO, et al. A comparative rheological study on carbopol viscous solutions and, the evaluation of their suitability as the ophthalmic vehicles and artificial tears. Pharm Acta Helv. 1992;67:5–10.
  • Mura P, Bettinetti G, Liguori A, et al. Formulation factors influencing the release of clonazepam from a carbopol hydrogel. Boll Chim Farm. 1979;128:326–331.
  • Smart J, Kellaway I, Worthington H. An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J Pharm Pharmacol. 1984;36(5):295–299.
  • Szilágyi BÁ, Mammadova A, Gyarmati B, et al. Mucoadhesive interactions between synthetic polyaspartamides and porcine gastric mucin on the colloid size scale. Colloids Surf B Biointerfaces. 2020;194:111219.
  • Deasy P, O'Neill C. Bioadhesive dosage form for peroral administration of timolol base. Pharm Acta Helv. 1989;64(8):231–235.
  • Escobar-Chávez JJ, López-Cervantes M, Naik A, et al. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci. 2006;9:339–358.
  • Jalaal M, Cottrell G, Balmforth N, et al. On the rheology of Pluronic F127 aqueous solutions. J Rheol. 2017;61(1):139–146.
  • Munkboel CH, Rasmussen TB, Elgaard C, et al. The classic azole antifungal drugs are highly potent endocrine disruptors in vitro inhibiting steroidogenic CYP enzymes at concentrations lower than therapeutic Cmax. Toxicology. 2019;425:152247.
  • Costa AF, Araujo DE, Cabral MS, et al. Development, characterization, and in vitro–in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis. Med Mycol. 2019;57(1):52–62.
  • Morrow JD. Fluconazole: a new triazole antifungal agent. Am J Med Sci. 1991;302(2):129–132.
  • Washton H. Review of fluconazole: a new triazole antifungal agent. Diagn Microbiol Infect Dis. 1989;12(4):229–233.
  • Helal DA, El-Rhman DA, Abdel-Halim SA, et al. Formulation and evaluation of fluconazole topical gel. Int J Pharm Pharm Sci. 2012;4:302–310.
  • Bisht R, Ghosh A, Upadhyaya K. Formulation, physiochemical characterization and in-vitro evaluation of antifungal bioadhesive vaginal tablet. Int J Pharm Technol. 2011;3:2270–2285.
  • Mahours GM, Sherif AYA, Shaaban DEZ, et al. Formulation and evaluation of fluconazole mucoadhesive vaginal tablets. BJPR. 2016;14(2):1–10.
  • Araujo VHS, Duarte JL, Carvalho GC, et al. Nanosystems against candidiasis: a review of studies performed over the last two decades. Crit Rev Microbiol. 2020;46(5):508–547.
  • Basha BN, Prakasam K, Goli D. Formulation and evaluation of gel containing fluconazole-antifungal agent. Int J Drug Dev Res. 2011;3:109–128.
  • Bachhav YG, Patravale VB. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. Int J Pharm. 2009;365(1-2):175–179.
  • Sarwal A, Singh G, Singh S, et al. Novel and effectual delivery of an antifungal agent for the treatment of persistent vulvovaginal candidiasis. J Pharm. Investig. 2019;49(1):135–147.
  • Roy A, Choudhury A, Bahadur S, et al. Phytoconstituent based mucoadhesive antifungal vaginal formulation: an effective and innovative approach. Biosci Biotech Res Comm. 2016;9(4):694–701.
  • Choudhury A, Roy A. Preparation and characterization of vagino-adhesive fluconazole gel. Res J Pharm Technol. 2016;9(8):1086–1090.
  • Kumar L, Reddy MS, Shirodkar RK, et al. Preparation and characterization of fluconazole vaginal films for the treatment of vaginal candidiasis. Indian J Pharm Sci. 2013;75:585–590.
  • Felimban AMJ, El Ala AEFA, Aleanizy FS, et al. Development and validation RP-HPLC method for quantification of fluconazole in pharmaceutical formulations. J Pharm Med Sci. 2020;4:27–35.
  • Abou El Ela AESF, Khatib MME. Formulation and evaluation of new long acting metoprolol tartrate ophthalmic gels. Saudi Pharm J. 2014;22(6):555–563.
  • Gilbert JC, Hadgraft J, Bye A, et al. Drug release from Pluronic F-127 gels. Int J Pharm. 1986;32(2–3):223–228.
  • Bhowmik BB, Nayak BS, Chatterjee A. Formulation development and characterization of metronidazole microencapsulated bioadhesive vaginal gel. Int J Pharm Pharm Sci. 2009;1:240–257.
  • Hussain A, Singh VK, Singh OP, et al. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of amphotericin B. Drug Deliv. 2016;23(8):3101–3110.
  • Al-Joufi FA, Aljarallah KM, Hagras SA, et al. Microbial spectrum, antibiotic susceptibility profile, and biofilm formation of diabetic foot infections (2014-18): a retrospective multicenter analysis. 3 Biotech. 2020;10(7):325.
  • Cassone A, Sobel JD. Experimental models of vaginal candidiasis and their relevance to human candidiasis. Infect Immun. 2016;84(5):1255–1261.
  • Petrova MI, Lievens E, Malik S, et al. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol. 2015;6:81.
  • Larsen B, Markovetz AJ, Galask RP. The bacterial flora of the female rat genital tract. Proc Soc Exp Biol Med. 1976;151(3):571–574.
  • Eisa EA. The formation of lactic acid in the vagina of the adult rat. Acta Endocrinol. 1950;4(3):285–290.
  • Martins JDS, Junqueira JC, Faria RL, et al. Antimicrobial photodynamic therapy in rat experimental candidiasis: evaluation of pathogenicity factors of Candida albicans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(1):71–77.
  • Machado RM, Tomas M, Palmeira-de-Oliveira A, et al. The vaginal sheet: an innovative form of vaginal film for the treatment of vaginal infections. Drug Dev Ind Pharm. 2020;46(1):135–145.
  • Khattab A, Ismail S. Formulation and evaluation of oxiconazole mucoadhesive nanoemulsion based gel for treatment of fungal vaginal infection. Int J Pharm Pharm Sci. 2016;8:33–40.
  • N'Guessan Gnaman KC, Bouttier S, Yeo A, et al. Characterization and in vitro evaluation of a vaginal gel containing Lactobacillus crispatus for the prevention of gonorrhea. Int J Pharm. 2020;588:119733.
  • da Silva JB, Cook MT, Bruschi ML. Thermoresponsive systems composed of poloxamer 407 and HPMC or NaCMC: mechanical, rheological and sol-gel transition analysis. Carbohydr Polym. 2020;240:116268.
  • Gaikwad VL, Yadav VD, Dhavale RP, et al. Effect of carbopol 934 and 940 on fluconazole release from topical gel formulation: a factorial approach. JCPR. 2012;2(2):487–493.
  • Varges PR, Costa CM, Fonseca BS, et al. Rheological characterization of Carbopol® dispersions in water and in water/glycerol solutions. Fluids. 2019;4:E3.
  • Dou Q, Karim AA, Loh XJ. Modification of thermal and mechanical properties of PEG-PPG-PEG copolymer (F127) with MA-POSS. Polymers. 2016;8(9):341.
  • Charoensumran P, Ajiro H. Controlled release of testosterone by polymer-polymer interaction enrich organogel as a novel transdermal drug delivery system: effect of lemonene/PG and carbon-chain length on drug permeability. Reac Func Polym. 2020;148:104461.
  • Shelke S, Deshmukh A, Shinde P, et al. Formulation and evaluation of fluconazole gel for topical application. Asian J Pharm Res Dev. 2021;9:52–56.
  • El-Hammadi MM, Arias JL. Nano-sized platforms for vaginal drug delivery. Curr Pharm Des. 2015;21(12):1633–1644.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.